SUB MAX STENT

Serial Number 97608293
Registration 7239954
700

Registration Progress

Application Filed
Sep 27, 2022
Under Examination
Approved for Publication
Sep 26, 2023
Published for Opposition
Sep 26, 2023
Registered
Dec 12, 2023

Basic Information

Serial Number
97608293
Registration Number
7239954
Filing Date
September 27, 2022
Registration Date
December 12, 2023
Published for Opposition
September 26, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 12, 2023
Registration
Registered
Classes
010

Rights Holder

Ceroflo Limited

11
Address
Galway Business Park
Dangan, Galway
IE

Ownership History

Ceroflo Limited

Original Applicant
11
Dangan, Galway IE

Ceroflo Limited

Owner at Publication
11
Dangan, Galway IE

Ceroflo Limited

Original Registrant
11
Dangan, Galway IE

Legal Representation

Attorney
LEIGH ANN LINDQUIST

USPTO Deadlines

Next Renewal Deadline
1618 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-12-12)
Due Date
December 12, 2029
Grace Period Ends
June 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description
Dec 12, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 12, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 24, 2023 APET A ASSIGNED TO PETITION STAFF
Oct 24, 2023 CHPB I CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sep 26, 2023 PUBO A PUBLISHED FOR OPPOSITION
Sep 26, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 21, 2023 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 6, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 22, 2023 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Aug 18, 2023 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Aug 16, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2023 CNRT R NON-FINAL ACTION WRITTEN
Jul 18, 2023 GNRT F NON-FINAL ACTION E-MAILED
Jul 18, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 11, 2023 DOCK D ASSIGNED TO EXAMINER
Mar 2, 2023 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 1, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 1, 2022 ALIE A ASSIGNED TO LIE
Dec 1, 2022 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 13, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 30, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 010
Surgical apparatus and instruments for medical use; medical equipment, devices and instruments, namely, equipment, devices and instruments for use in connection with angioplasty procedures, equipment, devices and instruments for use in connection with intracranial angioplasty procedures, computed tomography (CT) apparatus, medical and surgical apparatus, equipment, devices and instruments for detecting and treating disorders of the circulatory system throughout the body, MRI apparatus for medical purposes, X-ray CT scanners, a handheld ultrasound unit for diagnosing brain disorders, medical equipment, devices and instruments for use in connection with diagnosing and treating disorders of the circulatory system throughout the body; stents; medical stents; vascular stents; implantable vascular stents; stent delivery systems; intracranial stents; intracranial stent delivery systems; apparatus, equipment, devices and instruments for use in connection with treating disorders of the circulatory system throughout the body; apparatus, equipment, devices and instruments for treating disorders of the circulatory system throughout the body; delivery devices for delivering stents; and parts and fittings for all the aforesaid goods
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"STENT"